Medical News

RSS

Pfizer releases Phase III study results comparing VFEND-ERAXIS combination to VFEND for IA

Pfizer Inc. today reported the top-line results of an international Phase III clinical trial which compared the combination of VFEND (voriconazole) and ERAXISTM (anidulafungin) to VFEND monotherapy for primary therapy of invasive aspergillosis, a life-threatening invasive fungal infection that can develop as a complication in patients with compromised immune systems.

1 Oct 2011

Novel bipartite gene therapy for retinitis pigmentosa

In a paper published in the October 2011 issue of Experimental Biology and Medicine, a team of researchers at Columbia University Medical Center led by Stephen Tsang, MD, Ph.D have achieved temporary functional preservation of photoreceptors in a mouse model for retinitis pigmentosa (RP) using novel bipartite gene therapy.

1 Oct 2011

New AAOS guideline recommends how to reduce DVT, PE after joint replacement surgery

An updated clinical practice guideline released last week by the American Academy of Orthopaedic Surgeons (AAOS) Board of Directors recommends how to reduce the likelihood of blood clots after hip or knee replacement surgery, procedures that more than 800,000 Americans undergo each year. The new guideline suggests use of preventive treatments and advises against routinely screening patients after surgery using ultrasound imaging.

1 Oct 2011

Study calls for review of current treatment strategies, more research into stroke prevention

Doctors are underutilising crucial medication to prevent deadly strokes in those with a common type of heart condition, new research says, leading to fresh calls for a review of current treatment strategies and more research into stroke prevention.

1 Oct 2011

Researchers identify protein-based blood biomarkers in patients treated with EPO

Biomarkers in the bloodstream could provide a rapid assessment of therapeutic intervention in ischemic stroke and allow patient stratification

1 Oct 2011

MDC Partners acquires majority stake in Concentric Pharma

Concentric Pharma Advertising, one of the largest and fastest-growing healthcare advertising agencies in the country, announced today that MDC Partners, Inc., has acquired a majority stake in the company.

1 Oct 2011

Time to increase efforts against HIV/AIDS, TB

In a Huffington Post opinion piece, Kolleen Bouchane, director of ACTION, asks whether President Barack Obama will "heed Archbishop [Desmond] Tutu's call to action" in a recent Washington Post opinion piece "and do his part to end AIDS."

1 Oct 2011

TIMEX, KSI partner on research studies with athletes to improve performance and safety

To develop training products for athletes of all sports, TIMEX, a leader in outdoor and sports performance timepieces, is joining forces with the University of Connecticut's Korey Stringer Institute on a number of research and educational studies about heart rate zone/GPS training and the importance of using proper training equipment, during and after training and competition.

1 Oct 2011

ViroPharma licenses worldwide rights from Intellect Neurosciences to OX1 for treatment of FA

ViroPharma Incorporated today announced the license of worldwide rights from Intellect Neurosciences, Inc. to its clinical stage drug candidate, OX1, being developed for the treatment of Friedreich's Ataxia (FA), a rare, hereditary, progressive neurodegenerative disease.

1 Oct 2011

Viewpoints: Sebelius on improving care; Samuelson on health costs; Durenberger on exporting U.S. system

Far too many Americans still go without the best care. That's why the Obama administration has joined with Truman Medical Centers and more than 2,500 other hospitals nationwide, along with thousands of employers, health insurers, provider organizations and patient advocates, to launch the Partnership for Patients … Over the next three years, we will reduce preventable injuries in hospitals by 40 percent. And we will cut hospital re-admissions by 20 percent, targeting the return trips that should never have occurred.

1 Oct 2011

Blueberry powder may control triple negative breast cancer

In several studies recently conducted at the Beckman Research Institute at the City of Hope, Duarte, CA researchers found that feeding blueberry powder to mice significantly reduced the growth and spread of triple negative breast cancer cells, a very aggressive form of cancer.

1 Oct 2011

Researchers to create evaluation method to examine three childhood obesity programs

Projects and programs to combat childhood obesity have made great strides in health and behavior, yet the epidemic persists. Indeed, First Lady Michelle Obama's "Let's Move" initiative has made the issue of childhood obesity a focal point and national priority.

1 Oct 2011

Amorfix achieves 85% specificity and sensitivity with EP-AD CSF Diagnostic Test for AD

Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced it has achieved 85 percent specificity and sensitivity with its EP-AD CSF Diagnostic Test.

1 Oct 2011

TerraMedica changes company name to Fortel Analytics

Effective today, TerraMedica has changed its name to Fortel Analytics to reflect their focus on managing healthcare fraud and abuse prevention through advancing new and innovative predictive solutions, analysis methods and analytical technology.

1 Oct 2011

ShurTech Brands to donate $100,000 to BCRF

According to the American Cancer Society, after lung cancer, breast cancer is the second leading cause of cancer death in women. So, for the third consecutive year, ShurTech Brands, LLC, marketers of the Duck brand of duct tapes, packaging supplies and home products, is joining the fight to find a cure by contributing up to $100,000 to The Breast Cancer Research Foundation.

1 Oct 2011

Research roundup: What older patients really prize; DOD and the ACA

DOD Health Care: Cost Impact Of Health Care Reform And The Extension Of Dependent Coverage -- This study, mandated by Congress, assesses the financial impact of the federal health law on the Defense Department's budget.

1 Oct 2011

China's family planning policy, lack of sex education to blame for rise in abortions among single women

In this Washington Times opinion piece, Chai Ling, president of the non-profit group All Girls Allowed and author of "A Heart for Freedom," examines the issue of abortions performed on single women in China in relation to the country's family planning policy, which in most provinces requires couples to be married to obtain a birth permit, without which they are not permitted to have a child.

1 Oct 2011

AxoGen mergers with LecTec

AxoGen, Inc., the parent company of AxoGen Corporation, has announced completion of the merger between LecTec Corporation and AxoGen Corporation.

1 Oct 2011

New analyses from Phase III studies of VICTRELIS to be presented at AASLD 2011

Merck, known as MSD outside of the United States and Canada, announced today that several new analyses from Phase III studies of VICTRELIS (boceprevir), the company's first-in-class, oral hepatitis C virus NS3/4A protease inhibitor will be presented at the 62nd Annual Meeting of the American Association for the Study of Liver Diseases.

1 Oct 2011

Express Scripts launches suite of services through HealthBridge Pharma & Biotech

Express Scripts has launched a suite of services for pharmaceutical and biotech companies through HealthBridge Pharma & Biotech, providing a single-solution approach to patient care.

1 Oct 2011

Medical News

Pfizer releases Phase III study results comparing VFEND-ERAXIS combination to VFEND for IA

Novel bipartite gene therapy for retinitis pigmentosa

New AAOS guideline recommends how to reduce DVT, PE after joint replacement surgery

Study calls for review of current treatment strategies, more research into stroke prevention

Researchers identify protein-based blood biomarkers in patients treated with EPO

MDC Partners acquires majority stake in Concentric Pharma

Time to increase efforts against HIV/AIDS, TB

TIMEX, KSI partner on research studies with athletes to improve performance and safety

ViroPharma licenses worldwide rights from Intellect Neurosciences to OX1 for treatment of FA

Viewpoints: Sebelius on improving care; Samuelson on health costs; Durenberger on exporting U.S. system

Blueberry powder may control triple negative breast cancer

Researchers to create evaluation method to examine three childhood obesity programs

Amorfix achieves 85% specificity and sensitivity with EP-AD CSF Diagnostic Test for AD

TerraMedica changes company name to Fortel Analytics

ShurTech Brands to donate $100,000 to BCRF

Research roundup: What older patients really prize; DOD and the ACA

China's family planning policy, lack of sex education to blame for rise in abortions among single women

AxoGen mergers with LecTec

New analyses from Phase III studies of VICTRELIS to be presented at AASLD 2011

Express Scripts launches suite of services through HealthBridge Pharma & Biotech

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News